The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial

BACKGROUND: Several clinical trials and recent meta-analyses have demonstrated that administration of recombinant human granulocyte-colony stimulating factor (G-CSF) is safe and, only in patients with large acute myocardial infarction (AMI), is associated with an improvement in left ventricular ejec...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Trials
Главные авторы: Leone, Antonio Maria, D’Amario, Domenico, Teofili, Luciana, Basile, Eloisa, Cannata, Francesco, Graziani, Francesca, Marzilli, Mario, Russo, Antonio Matteo, Tarantini, Giuseppe, Ceconi, Claudio, Leone, Giuseppe, Trani, Carlo, Rebuzzi, Antonio Giuseppe, Crea, Filippo
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759781/
https://ncbi.nlm.nih.gov/pubmed/26891753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1172-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы